Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $15
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $15.
Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $15.